Hotel-Dieu de Quebec

Québec, Quebec G1R2J6

1 studies enrolling now · 3 studies all time

What they study most

Advanced Ovarian Cancer, BRCA Mutated, BRCA Mutation, Complete Response, Cutaneous Melanoma, Stage II, FIGO Stage III-IV, First Line Platinum Chemotherapy, Following Complete or Partial Response to Platinum Based Chemotherapy, Newly Diagnosed, Partial Response, Platinum Sensitive, Relapsed Ovarian Cancer

Studies at this site

• Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma — Recruiting now
• Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy — Running, not enrolling
• Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. — Running, not enrolling